aTyr Pharma Inc (LIFE) - Financial Analysis Review

Summary

aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that focuses on the discovery and development of Physiocrine-based therapies. Its lead candidate, resolaris, a potential intravenous protein therapeutic for the treatment of rare myopathies with an immune component. aTyr Pharma offers phyisiocrine, a class of endogenous human proteins from amino acyl tRNA synthetases that function as extracellular signaling molecules in different physiologic settings. The company develops drugs for cancer, neurodegenerative diseases, inflammation, and metabolic disorders. It conducts clinical trial of resolaris in adult patients with facioscapulohumeral muscular dystrophy (FSHD).

GlobalData's aTyr Pharma Inc (LIFE) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

aTyr Pharma Inc Key Recent Developments:

Nov 14,2016: aTyr Pharma Announces Third Quarter 2016 Operating Results
Oct 28,2016: aTyr Pharma receives FDA fast track designation for treatment of FSHD
Sep 21,2016: aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research
Aug 10,2016: aTyr Pharma Announces Second Quarter 2016 Operating Results
May 11,2016: aTyr Pharma Announces First Quarter 2016 Operating Results


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.